Diacerein retards cell growth of chondrosarcoma cells at the G2/M cell cycle checkpoint via cyclin B1/CDK1 and CDK2 downregulation

BACKGROUND: Chondrosarcoma is characterized for its lack of response to conventional cytotoxic chemotherapy, propensity for developing lung metastases, and low rates of survival. Research within the field of development and expansion of new treatment options for unresectable or metastatic diseases i...

Descripción completa

Detalles Bibliográficos
Autores principales: Lohberger, Birgit, Leithner, Andreas, Stuendl, Nicole, Kaltenegger, Heike, Kullich, Werner, Steinecker-Frohnwieser, Bibiane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4641423/
https://www.ncbi.nlm.nih.gov/pubmed/26555773
http://dx.doi.org/10.1186/s12885-015-1915-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4641423/
https://www.ncbi.nlm.nih.gov/pubmed/26555773
http://dx.doi.org/10.1186/s12885-015-1915-4

Ejemplares similares